IKZF1 and neoplasm: CC-122, a new chemical entity termed as pleiotropic pathway modifier, has been reported to have anti-tumor effect in both the activated B-cell (ABC) and the germinal center B-cell DLBCL, mainly by inducing the degradation or short hairpin RNA–mediated knockdown of Aiolos and Ikaros.